Senzime AB Total Liabilities
Senzime AB total liabilities. Based on the latest financial reports, Senzime AB (SEZI) has total liabilities worth Skr61.56 Million SEK (≈ $6.62 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Senzime AB (SEZI) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Senzime AB (2005–2025)
Total liabilities of Senzime AB from 2005 to 2025. This chart illustrates how Senzime AB's total liabilities have evolved over time, based on quarterly financial data.
Senzime AB Competitors by Total Liabilities
The table below lists competitors of Senzime AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ADOLFO DOMINGUEZ
MC:ADZ
|
Spain | €88.19 Million |
|
WPP PLC
LSE:WPP
|
UK | GBX19.99 Billion |
|
Hil Industries Bhd
KLSE:8443
|
Malaysia | RM171.13 Million |
|
Arlitech Electronic
TWO:6432
|
Taiwan | NT$461.80 Million |
|
American Creek Resources Ltd
V:AMK
|
Canada | CA$30.45K |
|
Young Heung I&
KO:012160
|
Korea | ₩235.50 Billion |
|
Global View Co Ltd
TW:3040
|
Taiwan | NT$574.45 Million |
|
Icure Pharmaceutical Incorporation
KQ:175250
|
Korea | ₩80.55 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Senzime AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Senzime AB total assets.
Liquidity & Leverage Metrics
Senzime AB Total Liabilities Ratios Explained
Senzime AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Senzime AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Senzime AB (2005–2025)
The table below shows the annual total liabilities of Senzime AB from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr65.35 Million ≈ $7.03 Million |
-18.83% |
| 2024-12-31 | Skr80.51 Million ≈ $8.66 Million |
+38.65% |
| 2023-12-31 | Skr58.06 Million ≈ $6.25 Million |
-4.46% |
| 2022-12-31 | Skr60.78 Million ≈ $6.54 Million |
+152.80% |
| 2021-12-31 | Skr24.04 Million ≈ $2.59 Million |
-12.72% |
| 2020-12-31 | Skr27.55 Million ≈ $2.96 Million |
+14.45% |
| 2019-12-31 | Skr24.07 Million ≈ $2.59 Million |
-19.10% |
| 2018-12-31 | Skr29.75 Million ≈ $3.20 Million |
+16.33% |
| 2017-12-31 | Skr25.57 Million ≈ $2.75 Million |
+4.63% |
| 2016-12-31 | Skr24.44 Million ≈ $2.63 Million |
+1126.44% |
| 2015-12-31 | Skr1.99 Million ≈ $214.46K |
-10.94% |
| 2014-12-31 | Skr2.24 Million ≈ $240.79K |
+91.47% |
| 2013-12-31 | Skr1.17 Million ≈ $125.76K |
-6.29% |
| 2012-12-31 | Skr1.25 Million ≈ $134.19K |
-67.12% |
| 2011-12-31 | Skr3.79 Million ≈ $408.17K |
-5.82% |
| 2010-12-31 | Skr4.03 Million ≈ $433.39K |
-11.76% |
| 2009-12-31 | Skr4.56 Million ≈ $491.13K |
-5.42% |
| 2008-12-31 | Skr4.83 Million ≈ $519.27K |
+11.44% |
| 2007-12-31 | Skr4.33 Million ≈ $465.98K |
+34.39% |
| 2006-12-31 | Skr3.22 Million ≈ $346.74K |
+7.22% |
| 2005-12-31 | Skr3.00 Million ≈ $323.39K |
-- |
About Senzime AB
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impeda… Read more